Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Snowsill TM"'
Autor:
Snowsill, TM, Stathi, A, Green, C, Withall, J, Greaves, CJ, Thompson, JL, Taylor, G, Gray, S, Johansen-Berg, H, Bilzon, JLJ, de Koning, JL, Bollen, JC, Moorlock, SJ, Western, MJ, Guralnik, JM, Rejeski, WJ, Fox, KR, Medina-Lara, A
Publikováno v:
Snowsill, T M, Stathi, A, Green, C, Withall, J, Greaves, C J, Thompson, J L, Taylor, G, Gray, S, Johansen-Berg, H, Bilzon, J L J, de Koning, J L, Bollen, J C, Moorlock, S J, Western, M J, Guralnik, J M, Rejeski, W J, Fox, K R & Medina-Lara, A 2022, ' Cost-effectiveness of a physical activity and behaviour maintenance programme on functional mobility decline in older adults : an economic evaluation of the REACT (Retirement in Action) trial ', Lancet Public Health, vol. 7, no. 4, pp. e327-e334 . https://doi.org/10.1016/S2468-2667(22)00030-5
Background Mobility limitations in older populations have a substantial impact on health outcomes, quality of life, and social care costs. The Retirement in Action (REACT) randomised controlled trial assessed a 12-month community-based group physical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec8e843f8dc60eae80c644ee4e6cf4d
https://pubmed.ncbi.nlm.nih.gov/35325628
https://pubmed.ncbi.nlm.nih.gov/35325628
Autor:
Snowsill TM; Health Economics Group, University of Exeter, Exeter, UK., Coelho H; Peninsula Technology Assessment Group, University of Exeter, Exeter, UK., Morrish NG; Health Economics Group, University of Exeter, Exeter, UK., Briscoe S; Exeter Policy Research Programme Evidence Review Facility, University of Exeter, Exeter, UK., Boddy K; NIHR Collaborations for Leadership in Applied Health Research and Care South West Peninsula, University of Exeter, Exeter, UK., Smith T; Lynch Syndrome, Exeter, UK., Crosbie EJ; Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK., Ryan NA; The Academic Women's Health Unit, University of Bristol, Bristol, UK.; Department of Obstetrics and Gynaecology, St Michael's Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Lalloo F; Manchester Centre for Genomic Medicine, Manchester University Hospitals Foundation Trust, Manchester, UK., Hulme CT; Health Economics Group, University of Exeter, Exeter, UK.
Publikováno v:
Health technology assessment (Winchester, England) [Health Technol Assess] 2024 Aug; Vol. 28 (41), pp. 1-228.
Autor:
Snowsill TM; University of Exeter Medical School, University of Exeter, Exeter, UK. Electronic address: t.m.snowsill@exeter.ac.uk., Stathi A; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK., Green C; University of Exeter Medical School, University of Exeter, Exeter, UK., Withall J; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK; Department for Health, University of Bath, Bath, UK., Greaves CJ; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK., Thompson JL; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK., Taylor G; University of Exeter Medical School, University of Exeter, Exeter, UK., Gray S; Faculty of Health and Applied Sciences, University of the West of England (UWE) Bristol, Bristol, UK., Johansen-Berg H; Wellcome Centre for Integrative Neuroimaging, John Radcliffe Hospital, University of Oxford, Oxford, UK., Bilzon JLJ; Department for Health, University of Bath, Bath, UK., de Koning JL; Department for Health, University of Bath, Bath, UK., Bollen JC; University of Exeter Medical School, University of Exeter, Exeter, UK., Moorlock SJ; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK., Western MJ; Department for Health, University of Bath, Bath, UK., Guralnik JM; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA., Rejeski WJ; Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, USA., Fox KR; Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, Bristol, UK., Medina-Lara A; University of Exeter Medical School, University of Exeter, Exeter, UK.
Publikováno v:
The Lancet. Public health [Lancet Public Health] 2022 Apr; Vol. 7 (4), pp. e327-e334. Date of Electronic Publication: 2022 Mar 21.
Autor:
Peters JL; Exeter Test Group, University of Exeter Medical School, St Luke's Campus, Exeter, England, UK. Electronic address: j.peters@exeter.ac.uk., Snowsill TM; Health Economics Group, University of Exeter Medical School, St Luke's Campus, Exeter, England, UK., Griffin E; University of Exeter, Exeter, England, UK., Robinson S; PenTAG, University of Exeter Medical School, St Luke's Campus, Exeter, England, UK., Hyde CJ; Exeter Test Group, University of Exeter Medical School, St Luke's Campus, Exeter, England, UK.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Apr; Vol. 25 (4), pp. 656-665. Date of Electronic Publication: 2021 Dec 11.
Autor:
Snowsill TM; Health Economics Group, University of Exeter Medical School, Exeter EX1 2LU, UK., Ryan NAJ; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.; Academic Centre for Women's Health, University of Bristol, Bristol BS8 2PS, UK., Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.; Division of Gynaecology, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2020 Jun 01; Vol. 9 (6). Date of Electronic Publication: 2020 Jun 01.
Autor:
Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK. Emma.crosbie@manchester.ac.uk.; Directorate of Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Emma.crosbie@manchester.ac.uk.; Prevention Early Detection Theme, NIHR Biomedical Research Centre, The Christie NHS Foundation Trust, Manchester, UK. Emma.crosbie@manchester.ac.uk., Ryan NAJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, UK., Arends MJ; Division of Pathology & Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK., Bosse T; Pathology Department, Leiden University Medical Center, Leiden, the Netherlands., Burn J; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK., Cornes JM; Patient Representative, Cambridge, UK., Crawford R; Department of Gynaecological Oncology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Eccles D; Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK., Frayling IM; Institute of Cancer and Genetics, Cardiff University, Cardiff, UK., Ghaem-Maghami S; Department of Surgery and Cancer, Imperial College, London, UK., Hampel H; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Kauff ND; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Kitchener HC; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK., Kitson SJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK., Manchanda R; Barts Cancer Institute, Queen Mary University of London, London, UK., McMahon RFT; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, UK., Monahan KJ; Chelsea & Westminster Hospital NHS Trust, London, UK., Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK., Møller P; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Oslo, Norway.; Research Group Inherited Cancer, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten-, Herdecke, Germany., Möslein G; Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten-, Herdecke, Germany., Rosenthal A; Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK., Sasieni P; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK., Seif MW; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.; Directorate of Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Skarrott P; Lynch Syndrome UK, Linden House, 9/11 Main Street, Ingleton, Carnforth, UK., Snowsill TM; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.; Health Economics Group, University of Exeter, Exeter, UK., Steele R; Division of Cancer, Medical Research Institute, Ninewells Hospital and Medical School, Dundee, UK., Tischkowitz M; Academic Laboratory of Medical Genetics, University of Cambridge, Cambridge, UK.; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK., Evans DG; Prevention Early Detection Theme, NIHR Biomedical Research Centre, The Christie NHS Foundation Trust, Manchester, UK.; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, UK.; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Oct; Vol. 21 (10), pp. 2390-2400. Date of Electronic Publication: 2019 Mar 28.
Autor:
Snowsill TM; Health Economics Group, University of Exeter Medical School, University of Exeter, Exeter, Devon, United Kingdom., Ryan NAJ; Division of Cancer Sciences, Faculty of Biology and Health, University of Manchester, Manchester, United Kingdom.; Division of Evolution and Genomic Medicine, Faculty of Biology and Health, University of Manchester, Manchester, United Kingdom., Crosbie EJ; Division of Cancer Sciences, Faculty of Biology and Health, University of Manchester, Manchester, United Kingdom.; Directorate of Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom., Frayling IM; Inherited Tumour Syndromes Research Group, Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom., Evans DG; Division of Evolution and Genomic Medicine, Faculty of Biology and Health, University of Manchester, Manchester, United Kingdom.; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom., Hyde CJ; Exeter Test Group, University of Exeter Medical School, University of Exeter, Exeter, Devon, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2019 Aug 30; Vol. 14 (8), pp. e0221419. Date of Electronic Publication: 2019 Aug 30 (Print Publication: 2019).
Autor:
Snowsill TM; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Moore J; Exeter Kidney Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Mujica Mota RE; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Peters JL; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Jones-Hughes TL; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Huxley NJ; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Coelho HF; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Lowe JA; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Varley-Campbell JL; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Allwood MJ; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK., Anderson R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2017 Jul 01; Vol. 32 (7), pp. 1251-1259.
Autor:
Tikhonova IA; Peninsula Technology Assessment Group, South Cloisters, Room 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK. I.Tikhonova@exeter.ac.uk., Hoyle MW; Peninsula Technology Assessment Group, South Cloisters, Room 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK., Snowsill TM; Peninsula Technology Assessment Group, South Cloisters, Room 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK., Cooper C; Peninsula Technology Assessment Group, South Cloisters, Room 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK., Varley-Campbell JL; Peninsula Technology Assessment Group, South Cloisters, Room 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK., Rudin CE; Royal Devon and Exeter Hospital, Exeter, UK., Mujica Mota RE; Peninsula Technology Assessment Group, South Cloisters, Room 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2017 Mar; Vol. 35 (3), pp. 363-373.